Literature DB >> 28844867

Integrated stress response stimulates FGF21 expression: Systemic enhancer of longevity.

Antero Salminen1, Kai Kaarniranta2, Anu Kauppinen3.   

Abstract

FGF21 is a multifunctional metabolic and stress hormone which is normally expressed in liver but cellular stress, e.g. mitochondrial or endoplasmic reticulum (ER) stress, can induce its expression and subsequent secretion from several mammalian tissues. The stress kinases of the integrated stress response (ISR) pathway stimulate the expression of FGF21 through the activation of ATF4 transcription factor, thus enhancing cellular stress resistance. The metabolic and stress-inducible transactivation mechanisms of FGF21 gene are mostly mediated through separate pathways. FGF21 is an interorgan regulator which can alleviate many age-related metabolic and stress disorders, e.g. through the activation of AMPK signaling. FGF21 signaling is also involved in circadian and torpor regulation. Given that circulating FGF21 can attenuate organelle stress, e.g. mitochondrial and ER stresses, it resembles a stress-induced cell non-autonomous regulation of proteostasis and longevity present in model organisms. The overexpression of FGF21 can even extend the lifespan of mice, probably by improving the healthspan. We will clarify the positive and negative signaling mechanisms which control the stress-related expression of FGF21 through the ISR pathway. Moreover, we will examine the role of FGF21 as an interorgan coordinator of survival functions in metabolic and stress disorders. We conclude that FGF21 can be viewed as a cell non-autonomous enhancer of longevity in mammals.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; Cell non-autonomous; FGF21; Healthspan; Klotho; Lifespan; PERK

Mesh:

Substances:

Year:  2017        PMID: 28844867     DOI: 10.1016/j.cellsig.2017.08.009

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  31 in total

Review 1.  Fibroblast growth factor 21 in chronic kidney disease.

Authors:  Paulo Giovanni de Albuquerque Suassuna; Rogério Baumgratz de Paula; Hélady Sanders-Pinheiro; Orson W Moe; Ming-Chang Hu
Journal:  J Nephrol       Date:  2018-11-14       Impact factor: 3.902

2.  αKlotho attenuates cardiac hypertrophy and increases myocardial fibroblast growth factor 21 expression in uremic rats.

Authors:  Paulo Giovani de Albuquerque Suassuna; Paula Marocolo Cherem; Bárbara Bruna de Castro; Edgar Maquigussa; Marco Antonio Cenedeze; Júlio Cesar Moraes Lovisi; Melani Ribeiro Custódio; Helady Sanders-Pinheiro; Rogério Baumgratz de Paula
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-17

Review 3.  Systemic effects of mitochondrial stress.

Authors:  Raz Bar-Ziv; Theodore Bolas; Andrew Dillin
Journal:  EMBO Rep       Date:  2020-05-24       Impact factor: 8.807

Review 4.  The roles of FGF21 in atherosclerosis pathogenesis.

Authors:  Farzane Shanebandpour Tabari; Ansar Karimian; Hadi Parsian; Vahid Rameshknia; Ata Mahmoodpour; Maryam Majidinia; Mahmood Maniati; Bahman Yousefi
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

5.  Roles of fibroblast growth factor 21 in the control of depression-like behaviours after social defeat stress in male rodents.

Authors:  Naoki Usui; Masahide Yoshida; Yuki Takayanagi; Naranbat Nasanbuyan; Ayumu Inutsuka; Hiroshi Kurosu; Hiroaki Mizukami; Yoshiyuki Mori; Makoto Kuro-O; Tatsushi Onaka
Journal:  J Neuroendocrinol       Date:  2021-08-09       Impact factor: 3.870

Review 6.  An overview of the molecular and physiological antidepressant mechanisms of physical exercise in animal models of depression.

Authors:  Lucas Renan Sena de Oliveira; Frederico Sander Mansur Machado; Isabella Rocha-Dias; Caíque Olegário Diniz E Magalhães; Ricardo Augusto Leoni De Sousa; Ricardo Cardoso Cassilhas
Journal:  Mol Biol Rep       Date:  2022-01-29       Impact factor: 2.742

7.  The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus.

Authors:  L-H Chang; C-M Hwu; C-H Chu; Y-C Lin; C-C Huang; J-Y You; H-S Chen; L-Y Lin
Journal:  J Endocrinol Invest       Date:  2021-04-08       Impact factor: 4.256

Review 8.  Low Protein Diets and Energy Balance: Mechanisms of Action on Energy Intake and Expenditure.

Authors:  Adel Pezeshki; Prasanth K Chelikani
Journal:  Front Nutr       Date:  2021-05-13

9.  OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21.

Authors:  Renata O Pereira; Alex Marti; Angela Crystal Olvera; Satya Murthy Tadinada; Sarah Hartwick Bjorkman; Eric Thomas Weatherford; Donald A Morgan; Michael Westphal; Pooja H Patel; Ana Karina Kirby; Rana Hewezi; William Bùi Trân; Luis Miguel García-Peña; Rhonda A Souvenir; Monika Mittal; Christopher M Adams; Kamal Rahmouni; Matthew J Potthoff; E Dale Abel
Journal:  Elife       Date:  2021-05-04       Impact factor: 8.140

10.  miR-125a induces apoptosis, metabolism disorder and migrationimpairment in pancreatic cancer cells by targeting Mfn2-related mitochondrial fission.

Authors:  Lichao Pan; Lin Zhou; Weijia Yin; Jia Bai; Rong Liu
Journal:  Int J Oncol       Date:  2018-04-26       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.